Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1623 1673 1681 1699 1759
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18582331 | DERMAL FILLER COMPOSITIONS | Non-Final OA | Allergan, Inc. |
| 18920285 | GLYCOSYLATION INHIBITORS AS THERAPEUTICS FOR STROKE | Final Rejection | The Regents of the University of California |
| 18323122 | NOVEL APPLICATIONS OF HYALURONIC ACID FOR TREATMENT OF PAIN AND PRURITIS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18262176 | Combination Therapy Schedules to Treat Cancer | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17996816 | COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES | Final Rejection | BAYER AKTIENGESELLSCHAFT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy